Logotype for MillerKnoll Inc

MillerKnoll (MLKN) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for MillerKnoll Inc

Q2 2026 earnings summary

5 Jan, 2026

Executive summary

  • Q2 FY2026 net sales were $955.2 million, down 1.6% year-over-year, while orders increased 5.5% to $972.5 million; organic sales declined 2.5% and organic orders rose 4.5%.

  • Adjusted EPS for Q2 FY2026 was $0.43, down 21.8% year-over-year; reported EPS was $0.35, down from $0.49 last year.

  • Gross margin improved by 20 basis points to 39.0%, driven by favorable product/channel mix and price increases.

  • Operating margin was 5.1%, down from 6.4% last year; adjusted operating margin was 5.9%.

  • Order growth was solid in every segment, with notable momentum in retail and contract businesses.

Financial highlights

  • Six-month net sales were $1,910.9 million, up 4.3% year-over-year; net earnings attributable to shareholders were $44.4 million, up 35%.

  • Adjusted EBITDA for FY25 was $359.8 million, down from $381.3 million in FY24.

  • Free cash flow for FY25 was $101.7 million, a decrease from $273.9 million in FY24.

  • Cash at Q2 FY26 was $180 million; long-term debt stood at $1,321 million; liquidity at quarter-end was $548.3 million.

  • Net debt-to-EBITDA ratio at 2.87x, below lending covenant limits.

Outlook and guidance

  • Q3 FY2026 net sales expected between $923 million and $963 million, with gross margin guidance of 37.9% to 38.9%.

  • Adjusted diluted EPS for Q3 expected between $0.42 and $0.48.

  • Full-year capital expenditures projected at $120 million–$130 million, focused on facilities and sustainability.

  • Guidance reflects seasonal softness in contract business and Chinese New Year timing.

  • Proactive pricing and tariff mitigation expected to offset tariff impacts in the second half.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more